Financhill
Back

Amicus Therapeutics Stock Predictions

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.1% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $9.80. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23.1% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
2.9B
Price in USD:
9.80
Volume:
3.5M
Beta:
0.99

Technical Analysis

SMA50:
10.45
SMA100:
10.77
SMA200:
10.64
52-Wk Change:
-23.68%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 9.80 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 9.90 9.79 9.99 9.72
Dec-4 9.80 9.86 9.99 9.75
Dec-5 9.80 9.76 9.89 9.72
Dec-6 9.82 9.73 9.97 9.57
Dec-9 9.76 9.83 10.00 9.74
Dec-10 9.87 10.13 10.20 9.82
Dec-11 10.14 10.16 10.36 10.09
Dec-12 10.06 10.15 10.20 10.02
Dec-13 9.85 9.36 9.91 9.30
Dec-16 9.37 9.90 9.99 9.28
Dec-17 9.86 9.89 9.97 9.72
Dec-18 9.87 9.57 9.93 9.42
Dec-19 9.58 9.73 9.87 9.44
Dec-20 9.68 9.80 9.88 9.60

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.